Daniel M. Geynisman

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial”.

Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial

The Lancet Oncology(2021)10.1016/s1470-2045(21)00004-8

N/A

5.8DataRank · unranked

418 citations

Maha Hussain, Jürgen E. Gschwend, Peter Albers, Stéphane Oudard, Daniel Castellano +21 more

Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

Journal of Clinical Oncology(2023)10.1200/jco.22.02887

N/A

4.4DataRank · unranked

181 citations

Matthew I. Milowsky, Daniel P. Petrylak, Christopher Hoimes, Thomas W. Flaig, Nataliya Mar +20 more

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2024)10.1056/nejmoa2401726

N/A

3.9DataRank · unranked

151 citations

Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh +35 more

A randomized phase 2 study of bicalutamide with or without metformin for biochemical recurrence in overweight or obese prostate cancer patients (BIMET-1)

Prostate Cancer and Prostatic Diseases(2022)10.1038/s41391-022-00492-y

N/A

0.873DataRank · unranked

22 citations

Nicole J. Toney, Renee N. Donahue, Susan Wróblewski, Matthew R. Zibelman, Pooja Ghatalia +9 more

Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates

JCO Precision Oncology(2024)10.1200/po.23.00362

N/A

0.262DataRank · unranked

3 citations

Henkel Valentine, David Liu, Michael J. Slifker, Costas D. Lallas, Edouard J. Trabulsi +24 more

Current Status and Future Direction to Address Disparities in Diversity, Equity, and Inclusion in Prostate Cancer Care

Current Oncology Reports(2023)10.1007/s11912-023-01399-0

N/A

0DataRank · unranked

20 citations

Chen Fu, Robert S. Wang, Daniel M. Geynisman, Pooja Ghatalia, Shannon M. Lynch +4 more

Cost-Effectiveness Analysis for Therapy Sequence in Advanced Cancer: A Microsimulation Approach with Application to Metastatic Prostate Cancer

Medical Decision Making(2023)10.1177/0272989x231201621

N/A

0DataRank · unranked

4 citations

J. Robert Beck, Andres Correa, Chethan Ramamurthy, Daniel M. Geynisman, Elizabeth A. Handorf

Role of Gut Microbiome in Neoadjuvant Chemotherapy Response in Urothelial Carcinoma: A Multi-Institutional Prospective Cohort Evaluation

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.21.525021

N/A

0DataRank · unranked

7 citations

Rashida Ginwala, Mohit Sindhani, Megan Prunty, Daniel M. Geynisman, Pooja Ghatalia +15 more

Metformin for biochemical recurrence of prostate cancer: Immune data from a phase 2 study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.377

N/A

0DataRank · unranked

1 citations

Nicole J. Toney, Renee N. Donahue, Fatima Karzai, Ravi A. Madan, Jeffrey Schlom +8 more

Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes

JCI Insight(2024)10.1172/jci.insight.183158

N/A

0DataRank · unranked

5 citations

Ella Boytim, Sean McSweeney, Negar Sadeghipour, Andrew Elliott, Rachel Passow +11 more

Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think tank meeting

Urologic Oncology Seminars and Original Investigations(2024)10.1016/j.urolonc.2024.10.022

N/A

0DataRank · unranked

5 citations

Salvatore La Rosa, Tian Zhang, Phillip M. Pierorazio, Laurence Albigès, Kathryn E. Beckermann +19 more

Bicalutamide with or without metformin for biochemical recurrence in prostate cancer patients (BIMET-1).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.85

N/A

0DataRank · unranked

0 citations

Matthew R. Zibelman, Pooja Ghatalia, Susan Wróblewski, Ravi A. Madan, Fatima Karzai +5 more

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Journal of Clinical Oncology(2025)10.1200/jco-25-01608

N/A

0DataRank · unranked

16 citations

Matthew D. Galsky, Nazlı Dizman, David H. Aggen, Neeraj Agarwal, Hikmat Al‐Ahmadie +39 more

A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.04.038

N/A

0DataRank · unranked

21 citations

Jodi K. Maranchie, Mark W. Ball, Gennady Bratslavsky, Eric A. Singer, Daniel M. Geynisman

Early Prostate-Specific Antigen Kinetics for Low- and Intermediate-Risk Prostate Cancer Treated With Definitive Radiation Therapy

Practical Radiation Oncology(2021)10.1016/j.prro.2021.07.003

N/A

0DataRank · unranked

2 citations

Chase C. Hansen, Mengying Deng, Elizabeth Handorf, Jonathan J. Paly, J.K. Wong +6 more

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study

European Urology(2023)10.1016/j.eururo.2023.01.017

N/A

0DataRank · unranked

56 citations

Michael A. O’Donnell, Jason A. Efstathiou, Marianna Zahurak, Gary L. Rosner, Jeff Smith +36 more

A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3642

N/A

0DataRank · unranked

38 citations

Galen Hostetter, Alexander W. Macfarlane, Zachary Madaj, Eric A. Ross, Toshinori Hinoue +22 more